FDA Adverse Event Malfunction Summary report: N

SAGB QUICK CLOSE

MDR report key: 1770644 · Received July 27, 2010

Report

Report Number
3005992282-2010-00218
Event Type
Malfunction
Date Received
July 27, 2010
Date of Event
February 3, 2010
Report Date
April 7, 2010
Manufacturer
OBTECH MEDICAL SARL_
Product Code
LTI
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE BAND WAS RETURNED WITH THE BUCKLE TORN FROM THE BAND. FOLDLINES WERE ALSO PRESENT ON THE BAND. THE BAND WAS LEAKED TEST AND NO LEAKS FOUND. IT IS NOTED THAT THE PRODUCT'S INSTRUCTION FOR USE (IFU) CAUTIONS AGAINST DAMAGING ANY PART OF THE BAND. AN ENGINEERING STUDY HAS BEEN PERFORMED TO TRY AND REPLICATE THE DAMAGE SEEN AT THE BUCKLE AREA AND IT IS NOTED THAT THIS FAILURE MODE COULD NOT BE REPLICATED WITHOUT PRIOR DAMAGE TO THE BAND BY A SHARP INSTRUMENT. IT IS THEREFORE TENTATIVELY SUGGESTED THAT THE REPORTED EVENT COULD BE THE RESULT OF INADVERTENT DAMAGE TO THE BAND AT THE TIME OF IMPLANT, ULTIMATELY RESULTING IN THE BUCKLE DAMAGE OBSERVED, HOWEVER, THIS CANNOT BE CONFIRMED. IT IS ALSO NOTED THAT THE DAMAGE OBSERVED TO THE BUCKLE WILL HAVE CONTRIBUTED TO THE REPORTED EVENT OF FAILURE TO LOSE WEIGHT. A DHR-REVIEW COULD NOT BE PERFORMED AS NO LOT NUMBER WAS COMMUNICATED. IT IS UNLIKELY THAT A MANUFACTURING ISSUE CONTRIBUTED TO THE REPORTED EVENT. ALL DEVICES ARE 100% VISUALLY INSPECTED PRIOR TO RELEASE.

Description of Event or Problem · 1

IT WAS REPORTED, THE GASTRIC BAND WAS REMOVED DUE TO POOR WEIGHT LOSS. THE SAGB PARTIALLY DISINTEGRATED DURING REMOVAL BY THE SURGEON. HE HAS ASKED FOR IT TO BE TESTED FOR QA. A REINSERTION OF A NEW SAGB WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE CONSEQUENCES FOR THE PATIENT. ONE DEVICE WILL BE RETURNED. (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SAGB QUICK CLOSE IMPLANT, INTRAGASTRIC FOR MORBID OBESITY LTI OBTECH MEDICAL SARL_ UNK ASKU

Patients

Seq Age Sex Outcome Treatment
1 43 YR